Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06492720 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT06492720 · ClinicalTrials.gov record · last posted 2026-04-09

A Pilot Study to Evaluate the Efficacy and Safety of NaviFUS™ System Neuromodulating Treatment for Patients With Drug Resistant Epilepsy

StatusRecruiting
PhaseNot applicable
Started2024-09-01
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
This will be a prospective, pilot, open-label, two-arm, parallel-group, randomized study to evaluate the efficacy and safety of low-intensity focused ultrasound (LIFU) neuromodulation using NaviFUS System in patients with drug-resistant epilepsy (DRE).

Amendment record 3 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 3 times since 2024-07-01; most recent amendment 2026-04-06. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2024-11-12
Status change Not Yet Recruiting→Recruitingv2
Trial Details
NCT Number NCT06492720
Lead Sponsor NaviFUS Corporation
Conditions Drug Resistant Epilepsy, Epilepsy, Epilepsy, Temporal Lobe, Seizures, Focal
Enrollment 16 participants
Start Date 2024-09-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-09